Heart transplantation in the United States, 1999-2008: Special Feature

American Journal of Transplantation

Volumn 10, Issue 4 PART 2, 2010, Pages 1035-1046

  Johnson, M R ^a   Meyer, K H ^b   Haft, J ^c   Kinder, D ^d   Webber, S A ^e   Dyke, D B ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b Scientific Registry of Transplant Recipients   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d California Transplant Donor Network   (United States)

^e CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Heart transplantation; OPTN; SRTR; Survival

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; DACLIZUMAB; EVEROLIMUS; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

AGE; ASSISTED CIRCULATION; BLOOD GROUP ABO INCOMPATIBILITY; CARDIOMYOPATHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; DRUG USE; ETHNICITY; GENDER; GEOGRAPHIC DISTRIBUTION; HEART FAILURE; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IMPLANT REGISTRY; LUNG FIBROSIS; MORTALITY; ORGAN DONOR; OUTCOME ASSESSMENT; PATIENT SELECTION; PEDIATRICS; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RACE DIFFERENCE; RETRANSPLANTATION; REVIEW; SEX DIFFERENCE; SURVIVAL; SURVIVAL RATE; TREND STUDY; UNITED STATES;

HEART TRANSPLANTATION; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; INFANT; REGISTRIES; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 77949822186     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03042.x     Document Type: Review

References (12)

1. Organ Procurement and Transplantation Network. Final analysis for data request from the OPTN Thoracic Organ Transplantation Committee meeting of November 21, 2008.
2. Rose EA, Gelijns AC, Moskowitz AJ et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001 345 : 1435 1443.
3. Patlolla V, Patten RD, Denofrio D, Konstam MA, Krishnamani R. The effect of ventricular assist devices on post-transplant mortality an analysis of the United network for organ sharing thoracic registry. J Am Coll Cardiol 2009 53 : 264 271.
4. Osaki S, Edwards NM, Johnson MR et al. Improved survival after heart transplantation in patients with bridge to transplant in the recent era: A 17-year single-center experience. J Heart Lung Transplant 2009 28 : 591 597.
5. Jabbour N, Long J, Horstmanhof D et al. Impact of ventricular assist device as bridge to heart transplantation in the United States (abstract). Am J Transplant 2009 9 (S2 194.
6. Miller LW, Pagani FD, Russell SD et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007 357 : 885 896.
7. Blume ED, Naftel DC, Bastardi HJ, Duncan BW, Kirklin JK, Webber SA. Outcomes of children bridged to heart transplantation with ventricular assist devices: A multi-institutional study. Circulation 2006 113 : 2313 2319.
8. Baldwin JT, Borovetz HS, Duncan BW et al. The national heart, lung, and blood institute pediatric circulatory support program. Circulation 2006 113 : 147 155.
9. West LJ, Pollock-Barziv SM, Dipchand AI et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001 344 : 793 800.
10. Dipchand AI, Pollock-Barziv SM, Manlhiot C, West LJ, VanderVliet M, McBrindle BW. Equivalent outcomes for pediatric heart transplantation recipients: ABO-blood group incompatible versus ABO-compatible. Am J Transplant 2010 10 : 389 397.
11. Magee JC, Barr ML, Basadonna GP et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant 2007 7 (5 Pt 2 1424 1433.
12. Johnson MR, Aaronson KD, Canter CE et al. Heart retransplantation. Am J Transplant 2007 7 : 2075 2081.